The 5 analysts offering 12-month price forecasts for Evelo Biosciences Inc have a median target of 15.00, with a high estimate of 36.00 and a low estimate of 11.00. The median estimate represents a +49.40% increase from the last price of 10.04.
The current consensus among 6 polled investment analysts is to Buy stock in Evelo Biosciences Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.51
Reporting Date Jun 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.